2BB score and signals
Sionna Therapeutics, Inc.’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 19 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 0 | Very Low |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2019 |
| Employees | 59 |
| 52-week range | $16.41 – $48.44 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.6574 | — | $0.00 |
| 2026-08-17 | — | -0.6625 | — | $0.00 |
| 2026-05-18 | — | -0.5284 | — | $0.00 |
| 2026-03-19 | — | -0.5531 | — | $0.00 |
2BBBullish & Bearish